Skip to main content

Aims and Scope

Diabetology & Metabolic Syndrome publishes articles on all aspects of the pathophysiology of diabetes and metabolic syndrome.

By publishing original material exploring any area of laboratory, animal or clinical research into diabetes and metabolic syndrome, the journal offers a high-visibility forum for new insights and discussions into the issues of importance to the relevant community.

The journal aims to help health care providers improve the management of people afflicted by these syndromes by increasing knowledge and stimulating research in the field.

Immunotherapy in type 1 diabetes

Sérgio Vencio: Institute of Pharmaceutical Sciences (ICF), Brazil
Marcello Casaccia Bertoluci: Universidade Federal do Rio Grande do Sul, Brazil
Submission Status: Open until 31 May 2024


  1. Authors: Amanda Godoi, Isabela Reis Marques, Eduardo M. H. Padrão, Ashwin Mahesh, Larissa C. Hespanhol, José Eduardo Riceto Loyola Júnior, Isabela A. F. de Souza, Vittoria C. S. Moreira, Caroliny H. Silva, Isabele A. Miyawaki, Christi Oommen, Cintia Gomes, Ariadne C. Silva, Kavita Advani and Joao Roberto de Sa

About the Editors

New Content ItemEditor-in-Chief
Dr. Sergio Vencio is an endocrinologist based in Goiania (Brazil), a member of the Brazilian Diabetes Society, principal investigator at Instituto de Ciências Farmacêuticas (ICP) and Technical Director of Laboratorio Jarbas Dole. 

New Content ItemDeputy Editor-in-Chief
Dr. Marcello Bertoluci is an endocrinologist based in Porto Alegre (Brazil) and Associate Professor at Universidade Federal do Rio Grande do Sul (UFRGS). He is currently Director of the Scientific Advisory Board of the Brazilian Diabetes Society.

Lipid metabolism disorders in diabetes

Andrea Baragetti: University of Milan, Italy
Giuseppina Russo: University of Messina, Italy

Submission Status: Open until 30 April 2024

Diabetes and Covid-19 Special Collection

New Content Item

In this Collection we publish research that investigates the relationships between diabetes and Covid-19 outcomes, as well as treatment and prognosis, physiopathology, epidemiology and any other impact that Covid-19 may have on diabetic patients’ health. 

OPEN FOR SUBMISSIONS | Check out what we have published so far!

Highly Accessed

Severity and mortality of COVID-19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis

Announcing the launch of In Review

Diabetology & Metabolic Syndrome, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

New Content Item

The official journal of the Brazilian Diabetes Society.

Annual Journal Metrics

  • 2022 Citation Impact
    4.8 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.476 - SNIP (Source Normalized Impact per Paper)
    1.195 - SJR (SCImago Journal Rank)

    2022 Speed
    2 days submission to first editorial decision for all manuscripts (Median)
    84 days submission to accept (Median)

    2022 Usage 
    3,375 Altmetric mentions